HHLA2 predicts better survival and exhibits inhibited proliferation in epithelial ovarian cancer

PURPOSE: The role of HHLA2, a new immune checkpoint ligand, is gradually being elucidated in various solid tumours. However, its role in ovarian cancer remains unclear; thus, its expression profile and clinical significance in ovarian cancer must be examined. METHODS: We performed immunohistochemist...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Cell Int
Main Authors: Xu, Guocai, Shi, Yuanyuan, Ling, Xiaoting, Wang, Dongyan, Liu, Yunyun, Lu, Huaiwu, Peng, Yongpai, Zhang, Bingzhong
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Primary Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8106145/
https://ncbi.nlm.nih.gov/pubmed/33962626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-021-01930-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados